AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Atreca to Present at the Cowen and Company Annual Health Care Conference

March 4, 2019

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Mar 4, 2019--Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today that John A. Orwin, President and Chief Executive Officer, will present at the Cowen and Company 39th Annual Health Care Conference. Mr. Orwin’s presentation will take place on Monday, March 11, 2019, at 2:30 p.m. Eastern Daylight Time at the Boston Marriott Copley Place.

About Atreca, Inc.

Atreca is a privately held biotechnology company developing novel therapeutics based on a deep understanding of the human immune response. Atreca focuses in a unique way on the immune responses of patients in therapeutic areas where such responses are the key phenomenon driving clinical outcomes, enabling the Company to discover and develop novel immunotherapies. Atreca is advancing a pipeline of candidates designed to engage the human immune response in oncology and other indications, thus driving better therapeutic outcomes. For more information on Atreca, please visit www.atreca.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190304005102/en/

CONTACT: Atreca, Inc.

Herb Cross

Chief Financial Officer

info@atreca.com

or

Media:

Nancie Steinberg, 212-213-0006, ext. 318

nsteinberg@burnsmc.com

Robert Flamm, 212-213-0006, ext. 364

rflamm@burnsmc.com

or

Investors:

Alex Gray, 212-213-0006, ext. 355

agray@burnsmc.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENERAL HEALTH

SOURCE: Atreca, Inc.

Copyright Business Wire 2019.

PUB: 03/04/2019 08:00 AM/DISC: 03/04/2019 08:01 AM

http://www.businesswire.com/news/home/20190304005102/en